Anti-parasitic drug Ivermectin is no longer allowed to be prescribed to COVID-19 patients.
The South African Health Products Regulatory Authority has terminated the controlled Compassionate Use Access Programme with immediate effect, saying there’s no credible evidence it helps treat COVID-19.
The authority had allowed it’s use in January last year amid public interest and reports of illicit Ivermectin entering the market.
It said that since the programme was introduced, more evidence has emerged around the efficacy of Ivermectin.
This includes the World Health Organization issuing an advisory that only recommended Ivermectin use within the context of clinical trials.
In South Africa, no further importation of unregistered Ivermectin products will be allowed and health facilities will no longer be enabled to hold bulk stock in anticipation of prescriptions.
More Stories
Arts Project Aimed At Preserving South African Culture
Ten Struggles Domestic Workers Face
Godongwana Harassment Claims Set To Be Discussed By ANC Integrity Commission
Eskom Cuts Illegal Connections In Cape Town
Mabuyane Rewards Loyalists
National Lotteries Commissioner Mampane Resigns
Solid Improvement In SA Business Debt Conditions in Q1 – Experian Data
Joburg Film Festival To Return In 2023
Amcu Marks 10th anniversary Of Marikana Massacre
Supreme Court Of Appeal Reserves Judgment In Zuma Matter
ANCWL Calls For Swift Action On Claims Against Godongwana
No Need To Panic Over Fourth Monkeypox Case – Dhlomo